V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220005358 | 220002100 | 1.62 | null | null | 2014-07-03 | 2014-07-03 | Cytarabine Low Dose | N | N | 220028015 | CYTARABINE |
| 220005359 | 220002100 | 1.75 | 60 | Curative (C) | 2013-08-19 | 2013-08-19 | AML17 TRIAL | Y | null | 220028015 | AML17 TRIAL |
| 220005360 | 220002101 | 1.56 | 78 | Curative (C) | 2017-10-28 | 2017-10-30 | AML17 TRIAL | 1 | null | 220028022 | AML17 TRIAL |
| 220005361 | 220002102 | null | null | null | 2017-10-29 | 2017-10-30 | Cytarabine Low Dose | N | N | 220028023 | CYTARABINE |
| 220005362 | 220011132 | 1.7 | 89.25 | Curative (C) | 2013-07-24 | 2013-07-25 | Trial Unspecified | 1 | N | 220028027 | TRIAL |
| 220005363 | 220011132 | 1.6 | 0 | Disease modification (D) | 2014-11-04 | 2014-11-05 | Trial Unspecified | Y | N | 220028027 | TRIAL |
| 220005364 | 220011132 | 1.74 | 0 | null | 2015-01-06 | 2015-01-07 | CYTARABINE | null | null | 220028027 | CYTARABINE |
| 220005365 | 220011132 | 1.75 | 0 | Palliative (P) | 2017-05-09 | 2017-05-09 | Cytarabine Low Dose | N | N | 220028027 | CYTARABINE |
| 220005366 | 220002103 | 1.66 | null | Curative (C) | 2014-12-28 | 2014-12-28 | AML17 TRIAL | Y | N | 220028037 | AML17 TRIAL |
| 220005367 | 220002103 | null | 74.4 | Curative (C) | 2016-02-08 | 2016-02-08 | Trial Unspecified | Y | N | 220028037 | TRIAL |
| 220005368 | 220002104 | 1.79 | null | Disease modification (D) | 2016-11-03 | 2016-11-03 | Trial Unspecified | N | N | 220028043 | TRIAL |
| 220005369 | 220002104 | 1.61 | 69.4 | Curative (C) | 2016-02-24 | 2016-02-24 | AML17 TRIAL | N | N | 220028043 | AML17 TRIAL |
| 220005375 | 220021218 | 1.88 | 96 | Curative (C) | 2015-03-06 | 2015-03-06 | AML17 TRIAL | N | null | 220028050 | AML17 TRIAL |
| 220005376 | 220002106 | 1.47 | 60.5 | Curative (C) | 2017-09-28 | 2017-09-28 | Trial Unspecified | 1 | N | 220028053 | TRIAL |
| 220005377 | 220002106 | 1.7 | null | Palliative (P) | 2016-02-02 | 2016-02-02 | LI-1 TRIAL | 01 | N | 220028053 | TRIAL |
| 220005378 | 220002106 | 1.76 | null | Not known (9) | 2013-11-07 | 2013-11-19 | CYTARABINE | 2 | null | 220028053 | CYTARABINE |
| 220005379 | 220002107 | 0 | 89.4 | Not known (9) | 2016-01-12 | 2016-02-17 | Trial Unspecified | Y | N | 220028057 | TRIAL |
| 220005380 | 220002108 | 1.64 | null | Not known (9) | 2013-07-18 | 2013-07-18 | Trial Unspecified | Y | N | 220028058 | TRIAL |
| 220005381 | 220002109 | null | 106.6 | Curative (C) | 2016-02-22 | 2016-02-26 | AML17 TRIAL | Y | N | 220028059 | AML17 TRIAL |
| 220005382 | 220002109 | 1.9 | null | Curative (C) | 2013-12-13 | 2013-12-13 | AML17 TRIAL | 02 | null | 220028059 | AML17 TRIAL |
| 220005383 | 220002109 | 1.79 | 65.4 | Palliative (P) | 2016-04-14 | 2016-04-14 | Cytarabine low (10to20mg/m2) IV/SC | 02 | N | 220028059 | CYTARABINE |
| 220005384 | 220018741 | 0 | 0 | Curative (C) | 2013-10-08 | 2013-10-08 | Trial Unspecified | Y | N | 220028063 | TRIAL |
| 220005385 | 220018741 | 1.62 | 93 | null | 2016-05-01 | 2016-05-01 | AML17 TRIAL | 01 | N | 220028063 | AML17 TRIAL |
| 220005386 | 220002110 | 1.63 | 60 | Not known (9) | 2017-07-24 | 2017-07-25 | AML17 TRIAL | N | N | 220028069 | AML17 TRIAL |
| 220005387 | 220002110 | 1.8 | 144.7 | Curative (C) | 2014-12-21 | 2014-12-21 | AML17 TRIAL | N | N | 220028069 | AML17 TRIAL |
| 220005388 | 220002110 | null | null | Curative (C) | 2016-11-18 | 2016-11-25 | AML17 TRIAL | Y | N | 220028069 | AML17 TRIAL |
| 220005389 | 220002110 | 1.71 | 72.3 | Palliative (P) | 2015-10-19 | 2015-10-20 | Trial Unspecified | N | N | 220028069 | TRIAL |
| 220005390 | 220002110 | 1.63 | null | Palliative (P) | 2017-10-15 | 2017-10-15 | Cytarabine Low Dose | N | N | 220028069 | CYTARABINE |
| 220005391 | 220002110 | 1.62 | 43.8 | Curative (C) | null | 2016-03-24 | AML17 TRIAL | 02 | N | 220028069 | AML17 TRIAL |
| 220005392 | 220002110 | 1.8 | 91 | Curative (C) | 2015-08-10 | 2015-08-10 | AML17 TRIAL | N | N | 220028069 | AML17 TRIAL |
| 220005393 | 220002110 | 0 | 95.2 | Palliative (P) | 2016-05-01 | 2016-05-03 | Cytarabine Low Dose | 02 | N | 220028069 | CYTARABINE |
| 220005394 | 220002110 | 1.63 | null | Curative (C) | 2013-01-17 | 2013-01-17 | CYTARABINE | 2 | N | 220028069 | CYTARABINE |
| 220005395 | 220002111 | 1.76 | 101 | Palliative (P) | null | 2017-11-22 | CYTARABINE | null | null | 220028095 | CYTARABINE |
| 220005396 | 220002111 | 0 | 111.6 | Palliative (P) | 2017-12-28 | 2018-01-11 | LI-1 TRIAL | Y | N | 220028095 | TRIAL |
| 220005397 | 220002111 | 1.78 | 93.3 | Curative (C) | 2016-06-18 | 2016-06-19 | Cytarabine Low Dose | Y | N | 220028095 | CYTARABINE |
| 220005398 | 220002112 | 0 | 0 | null | 2017-02-01 | 2017-02-01 | Trial Unspecified | Y | N | 220028100 | TRIAL |
| 220005399 | 220002112 | 1.84 | 0 | Palliative (P) | null | 2015-12-28 | Cytarabine Intrathecal (any age) | N | N | 220028100 | CYTARABINE |
| 220005400 | 220002112 | 1.71 | 73.2 | null | 2015-04-28 | 2015-04-28 | Trial Unspecified | 01 | N | 220028100 | TRIAL |
| 220005401 | 220002113 | 1.54 | 85.7 | Palliative (P) | 2017-06-05 | 2017-06-05 | Cytarabine Low Dose | 2 | null | 220028106 | CYTARABINE |
| 220005402 | 220002113 | 1.77 | 0 | Disease modification (D) | 2015-08-10 | 2015-08-15 | Cytarabine Low Dose | N | N | 220028106 | CYTARABINE |
| 220005403 | 220002113 | null | null | Disease modification (D) | 2015-09-14 | 2015-09-21 | Cytarabine low (10to20mg/m2) IV/SC | 2 | N | 220028106 | CYTARABINE |
| 220005404 | 220002113 | null | 84.6 | null | 2014-12-13 | 2014-12-13 | CYTARABINE | N | N | 220028106 | CYTARABINE |
| 220005405 | 220002113 | 1.68 | 71 | Curative (C) | 2017-08-20 | 2017-08-20 | AML17 TRIAL | N | N | 220028106 | AML17 TRIAL |
| 220005406 | 220002114 | 1.67 | 64.3 | Curative (C) | 2016-06-20 | 2016-06-20 | AML17 TRIAL | 02 | N | 220028118 | AML17 TRIAL |
| 220005407 | 220002114 | null | 81.2 | null | null | 2015-09-09 | Cytarabine low (10to20mg/m2) IV/SC | null | null | 220028118 | CYTARABINE |
| 220005408 | 220002114 | 0 | 84.4 | Palliative (P) | 2016-01-09 | 2016-01-11 | Trial Unspecified | 01 | N | 220028118 | TRIAL |
| 220005409 | 220002114 | null | 78 | Disease modification (D) | 2017-11-05 | 2017-11-06 | Cytarabine Low Dose | 01 | null | 220028118 | CYTARABINE |
| 220005410 | 220002115 | 1.57 | 87 | Curative (C) | 2015-09-21 | 2015-09-21 | AML17 TRIAL | 02 | N | 220028127 | AML17 TRIAL |
| 220005411 | 220011143 | null | 52.4 | Disease modification (D) | 2013-06-29 | 2013-06-29 | CYTARABINE | N | N | 220028129 | CYTARABINE |
| 220005412 | 220011143 | 1.73 | 64.3 | Curative (C) | 2015-01-05 | 2015-01-08 | AML17 TRIAL | 01 | N | 220028129 | AML17 TRIAL |